Drug Target Review

DECEMBER 20, 2024

Smith states, weve definitely come across people in the pharma industry who worry that AI means companies might steal our data or use it in harmful ways. As the industry gains more exposure to AIs real-world applications and the rigorous standards AI companies adhere to, trust will continue to grow.

Clinical Trials 128

Clinical Trials Trials Pharmaceuticals Drug Development 128

Drug Patent Watch

JANUARY 9, 2025

Enter the Contract Development and Manufacturing Organization (CDMO) a lifeline for many startups looking to bring their innovative therapies to market. The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation.

Compliance 52

Compliance Drug Development Pharma Companies Therapies 52

Drug Target Review

MAY 23, 2023

Therapies developed in recent decades have transformed the treatment of IBD, making hospitalisation and surgery less common. However, many patients respond poorly to corticosteroid treatment, or their immune system responds unfavourably to biological therapies, such as the development of autoimmune diseases.

Drugs 75

Drugs Small Molecule Production Disease 75

H1 Blog

DECEMBER 11, 2024

In 2025, I predict that there will be global regulations requiring comprehensive diversity plans for all major markets, including the EU and EMEA. As these standards take shape, pharma companies will adopt tools and models to reach broader and more diverse participants.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

The Pharma Data

DECEMBER 17, 2020

Goater is CEO at Surface Oncology, an immuno-oncology company developing next-generation antibody therapies. TISSIUM – France’s TISSIUM announced Michel Thérin has been appointed to the company ’ s board of directors. Thérin is the president of Advanced Therapies at Siemens Healthineers. Immune Regulation – U.K.-based

Small Molecule 52

Small Molecule Clinical Development Engineering Pharmaceuticals 52

Codon

FEBRUARY 13, 2024

Tom Ireland writes about the companies and technologies that are reimagining phage therapy. Soon after its publication, scientists, journalists, and investors were revisiting ‘phage therapy’ as a promising alternative to our failing antibiotics. Read it on our website here. Illustration by David S. Always free.

Therapies 135

Therapies Virus DNA Clinical Trials 135

The Anticancer Fund

JUNE 7, 2022

However, patients treated with subsequent therapies, including rechallenge with previous treatments some showed very encouraging responses - intriguingly suggesting the combination treatment may work to reverse drug resistance in this population with few other options.

Drugs 40

Drugs Clinical Trials Trials Treatment 40